Condensed Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues:
Premiums	$ 77,988	$ 72,786
Investment and other income	1,011	798
Total revenues	99,796	91,931
Operating costs:
Medical Costs	65,735	59,845
Operating costs	14,077	13,625
Cost of products sold	11,056	9,405
Depreciation and amortization	997	970
Total operating costs	91,865	83,845
Earnings from operations	7,931	8,086
Interest expense	(844)	(754)
Loss on sale of subsidiary	(7,086)	0
Earnings before income taxes	1	7,332
Provision for income taxes	(1,222)	(1,558)
Net (loss) earnings	(1,221)	5,774
Earnings attributable to noncontrolling interests	(188)	(163)
Net (loss) earnings attributable to UnitedHealth Group common shareholders	$ (1,409)	$ 5,611
(Loss) earnings per share attributable to UnitedHealth Group common shareholders:
Basic	$ (1.53)	$ 6.01
Diluted	$ (1.53)	$ 5.95
Basic weighted-average number of common shares outstanding	922	933
Dilutive effect of common share equivalents	0	10
Diluted weighted-average number of common shares outstanding	922	943
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	15	5
Products
Revenues:
Revenue from Products and Services	$ 11,909	$ 10,267
Services
Revenues:
Revenue from Products and Services	$ 8,888	$ 8,080